On-Demand Webinar: “CiPA Validation of hiPSC-Derived Cardiomyocytes for Drug Safety Evaluation” – June 9th
Join expert speakers at our upcoming webinar
Author: Guest Author
The Axol Blog
AXOL Blog
Overcoming Challenges in the iPSC Field – reflections from ISSCR 2022
ISSCR2022 enabled scientists, vendors and investors to meet face-to-face for…
Author: Adam Tozer
7 Reasons Why You Should Use Axol’s Human iPSC-Derived Motor Neurons in Your Assays
Spheroid culture of motor neurons generates mature cells with axons…
Author: Adam Tozer
Axol Bioscience raises £3.2 million GBP (c. $4.2 million USD)
Extension of previous funding round brings total raised to £7…
Author: Adam Tozer
The rise of hiPSC-Derived Motor Neurons as a physiologically relevant model for drug discovery
Read about how iPSC-derived cells can enhance your drug development…
Author: Axol Bioscience Ltd
Culturing Microglia? Which collagen you use could impact cell morphology
Human iPSC-derived microglia as an Alzheimer’s Disease model
Author: Axol Bioscience Ltd
Can We Model Neuroimmune Diseases in a Dish?
A look at the power of induced pluripotent stem cell…
Author: Adam Tozer
Using hiPSC-Derived Renal Proximal Tubular Cells in vitro assays to advance disease research and drug development
The rising numbers of kidney patients and a shortage of…
Author: Michelle Ricketts
Axol Bioscience Launches iPSC-Derived Astrocyte Kits
Cambridge, UK, 12 May 2016: Axol Bioscience, a biotechnology company…
Author: Michelle Ricketts
Axol Travel Grant Recipient: International Society for Stem Cell Research 2017
Axol Bioscience Travel Grant recipient, Helen Rowland, attended the ISSCR…
Author: Guest Author
Axol Bioscience Announces Custom Cell and Tissue Sourcing Service
The human cell culture specialists launch primary cell and tissue…
Author: Michelle Ricketts
Axol Bioscience Appoints Chief Business Officer
The stem cell disease model specialists, consolidate and ensure further…
Author: Richard Thomas
Better Assays Are Key to Understanding Neurological Conditions Caused by COVID-19
In a recent study from the University of Oxford, UK,…
Author: Adam Tozer